Loading…
← CockpitCompetitor Analysis › 4DX.AX 4DMedical Ltd.Open in the cockpit ↗

4DMedical Ltd.4DX.AXCompetitor analysis, valuation and peers

Australia · AUD·Information Technology›Information Technology Services

Australian medical-imaging company whose XV Technology turns standard X-ray/CT scans into 4D lung ventilation and blood-flow maps.

≈ A niche pulmonary-imaging software firmMomentum laggard 3
Mkt cap
$893M
US dollars, full cap
Free float
84%
of shares outstanding
$/day
$10.5M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
n/a
WACC 13.4%
Hurdle
n/a
no reverse DCF
Next earnings
100 days
26 Feb 2027
Close · AUDA$2.15
1D+0.9%
1W-9.3%
1M-42.4%
3M-43.9%
6M-37.9%
YTD-45.3%
1Y+44.8%
ATR %10.9%
52w lowhigh71.5% off high

What 4DMedical does

Australian medical-imaging company whose XV Technology turns standard X-ray/CT scans into 4D lung ventilation and blood-flow maps.

In one line: A niche pulmonary-imaging software firm.

Products and services

  • XV Technology / XV LVAS
  • Lung ventilation analysis software

Customers

  • Hospitals and radiology clinics
  • Pulmonologists

Where it sits in the supply chain

  • Medical devices
  • Diagnostic imaging software
  • Respiratory/pulmonary imaging

What could go right

  • Reimbursement/coding wins in US
  • Hospital adoption of 4D lung imaging

What could go wrong

  • Slow hospital sales cycles
  • Cash burn before profitability

Moat: narrow (IP / patents, regulatory licence). FDA/TGA-cleared imaging algorithm; regulatory clearance is a barrier for new entrants.

Headquarters: Melbourne, Australia · Founded: 2013 · Employees: 181

Named competitors

4DMedical at a glance

Size 4DMedical (4DX.AX) is an Australia Information Technology company (Information Technology Services) with a market value of $893M, the 181st largest of 317 Australia companies the cockpit tracks. Shares closed at A$2.15 on 18 Nov 2026.

Performance Over six months the shares fell 37.9%, against +12.6% for the median peer and +1.2% for the Australia market (cap-weighted) — 2nd lowest of 21 in its peer set.

Growth Revenue grew 20.6% over the last twelve months (peer median +6.5%); the operating margin is -813.7% (peer median 8.9%).

Valuation It trades at 151.2× enterprise value to sales against a peer median of 2.3× (most expensive of 21).

Next results Next results expected around 26 Feb 2027 (exchange calendar; dates can move).

Relative performance

7510012515021 May 202621 Aug 202618 Nov 2026Peer median 1114DX.AX 65
Six months, rebased to 100: 4DMedical against the median of its 20 peers (local-currency closes).

4DMedical financials

Reported figures in AUD; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
RevenueA$7.06MA$7.06MA$5.85MA$3.75MA$718,581
Revenue growth—+21%+56%+422%—
Gross profit-A$38.1M-A$38.1M-A$32.0M-A$28.4M-A$24.3M
EBITDA-A$52.0M-A$52.0M-A$42.2M-A$44.2M-A$42.0M
Net income-A$204M-A$204M-A$30.1M-A$36.0M-A$31.5M
Free cash flow-A$32.2M-A$32.2M-A$34.6M-A$31.0M-A$23.1M
Capital expenditureA$2.40MA$2.40MA$1.35MA$1.17MA$1.61M
Total debtn/aA$11.2MA$4.31MA$5.12MA$5.14M

Quarterly statements and history in the cockpit →

4DMedical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%-40%-20%0%+20%300226600797002421000503300598OSPNASEMAX446A4417TANLA23173003000023803762ANOD-BGDYN4DX.AX6-month return →1-month return →
Up and to the right = strong over both horizons. 4DMedical is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%+20%0×50×100×150×300226600797002421000503300598OSPNMAX446A4417TANLA300300MITK0022324DX.AXRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. 4DMedical is the large dot.

4DMedical competitors and peer comparison

Head to head with its named competitors (4DX.AX vs GEHC vs SHL.DE)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
4DMedical 4DX.AX$893M-38%+21%-814%151.2×n/a
GE HealthCare GEHC$37.8B+30%+7%14%2.1×5.0%
Siemens Healthineers SHL.DE$53.7B+27%+1%14%2.6×9.6%

How 4DMedical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

4DMedical against its 20 peers (data as of 18 Nov 2026)
Measure4DX.AXPeer medianRank in peer set
1-month return-42.4%-6.1%lowest of 21
6-month return-37.9%+12.6%2nd lowest of 21
Distance from 52-week high-71.5%-31.6%lowest of 21
Revenue growth (TTM)+20.6%+6.5%3rd highest of 21
Operating margin-813.7%8.9%lowest of 21
EV / Sales151.2×2.3×most expensive of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
4DMedical 4DX.AXAustralia$893M-38%+21%-814%151.2×n/an/a
Shanghai Ganglian E-Commerce 300226.SZChina$889M-26%+1%0%0.1×4.9%+3.9%
Insigma Technology 600797.SSChina$898M-31%-13%0%1.9×19.0%-2.9%
Shenzhen Das Intellitech 002421.SZChina$904M-10%-17%-17%3.5×13.1%-8.8%
China Reform Health Management & Services 000503.SZChina$936M-16%+6%-45%18.2×n/an/a
ArcherMind Technology 300598.SZChina$847M-30%+7%-5%2.6×n/an/a
OneSpan OSPNUnited States$844M+78%+5%18%3.2×16.1%+2.4%
Asseco South Eastern Europe ASE.WAPoland$950M+17%+7%16%2.0×-0.1%+11.9%
Wonders Information 300168.SZChina$952M-21%+3%-17%4.1×49.4%-7.6%
MediaAlpha MAXUnited States$838M+69%+15%7%0.7×-0.5%+13.7%
Northsand,Inc 446A.TJapan$969M+99%+60%21%4.2×-0.6%n/a
Global Security Experts 4417.TJapan$815M+202%+25%21%10.5×34.7%+30.2%
Tanla Platforms TANLA.NSIndia$991M+33%+18%14%1.7×16.7%+13.5%
Systena 2317.TJapan$998M+8%+6%16%1.3×-11.1%+9.2%
Strait Innovation Internet 300300.SZChina$797M-30%-8%-61%34.9×n/an/a
Nanjing Sciyon Wisdom Technology 002380.SZChina$792M-45%+7%12%1.9×6.8%+17.4%
Mitek Systems MITKUnited States$789M+18%+11%18%3.8×11.6%+12.1%
TechMatrix 3762.TJapan$786M+68%+15%10%1.4×-7.4%+18.3%
Qiming Information Technology 002232.SZChina$776M-26%-4%1%5.6×n/an/a
Addnode ANOD-B.STSweden$772M+18%+5%10%1.8×3.7%+8.8%
Grid Dynamics GDYNUnited States$1.05B+83%+7%4%1.8×28.1%+29.9%

Questions

Who are 4DMedical's main competitors?
Named competitors: Fluidda (private or unlisted), Imbio (private or unlisted), GE HealthCare (GEHC), Siemens Healthineers (SHL.DE). The cockpit's measured peer set (industry) also includes Shanghai Ganglian E-Commerce (300226.SZ), Insigma Technology (600797.SS), Shenzhen Das Intellitech (002421.SZ), China Reform Health Management & Services (000503.SZ), ArcherMind Technology (300598.SZ), OneSpan (OSPN).
Is 4DMedical expensive compared with its peers?
On ev / sales it trades at 151.2× against a peer median of 2.3×, most expensive of 21 in its peer set.
How has 4DMedical stock performed?
Over six months to 18 Nov 2026 the shares returned -37.9% against +12.6% for the median peer; over one year +44.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.